Last updated on December 2016

Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee.


Brief description of study

Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee.

Detailed Study Description

The purpose of this study is to evaluate the safety and effectiveness of a new experimental medication for the treatment of moderate to severe osteoarthritis of the hip or knee.

Clinical Study Identifier: TX15415

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Svitlana Shylman

SPRI Clinical Trials Brooklyn
Brooklyn, NY USA
  Connect »